Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy
Joshua M. Hare, MD, Joel E. Fishman, MD, PhD, Gary Gerstenblith, MD, Darcy L. DiFede Velazquez, RN, BSN, Juan P. Zambrano, MD, Viky Y. Suncion, MD, Melissa Tracy, MD, Eduard Ghersin, MD, Peter V. Johnston, MD, Jeffrey A. Brinker, MD, Elayne Breton, BSN, RN, Janice Davis-Sproul, MAS, Ivonne H. Schulman, MD, John Byrnes, MD, Adam M. Mendizabal, MS, Maureen H. Lowery, MD, Didier Rouy, MD, PhD, Peter Altman, PhD, Cheryl Wong Po Foo, PhD, Phillip Ruiz, MD, Alexandra Amador, BSMT, Jose Da Silva, PhD, Ian K. McNiece, PhD, Alan W. Heldman, MD
JAMA. 2012;308(22):2369-2379.
Published online December 12, 2012
Select Pricing Criteria: